Gerstein Fisher bought a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 1,810 shares of the company’s stock, valued at approximately $295,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of HSIC. FineMark National Bank & Trust boosted its position in Henry Schein by 3.3% in the third quarter. FineMark National Bank & Trust now owns 651 shares of the company’s stock worth $106,000 after buying an additional 21 shares during the last quarter. Advisor Group Inc. raised its stake in shares of Henry Schein by 33.9% in the third quarter. Advisor Group Inc. now owns 817 shares of the company’s stock worth $133,000 after buying an additional 207 shares during the period. FTB Advisors Inc. raised its stake in shares of Henry Schein by 12.0% in the third quarter. FTB Advisors Inc. now owns 978 shares of the company’s stock worth $152,000 after buying an additional 105 shares during the period. Sphera Funds Management LTD. purchased a new stake in shares of Henry Schein during the third quarter worth approximately $163,000. Finally, Trust Co. of Vermont raised its stake in shares of Henry Schein by 76.3% in the third quarter. Trust Co. of Vermont now owns 1,086 shares of the company’s stock worth $177,000 after buying an additional 470 shares during the period. 92.56% of the stock is owned by hedge funds and other institutional investors.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) traded up 0.13% during trading on Friday, reaching $165.07. The company’s stock had a trading volume of 278,080 shares. The stock’s 50 day moving average price is $158.28 and its 200-day moving average price is $159.07. The firm has a market cap of $13.29 billion, a PE ratio of 27.41 and a beta of 1.02. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $183.00.
A number of analysts have recently commented on the company. Robert W. Baird upgraded Henry Schein from a “neutral” rating to an “outperform” rating and boosted their price target for the company from $164.00 to $170.00 in a report on Tuesday, January 3rd. Zacks Investment Research lowered Henry Schein from a “hold” rating to a “sell” rating in a report on Monday, January 9th. Northcoast Research lowered Henry Schein from a “buy” rating to a “neutral” rating in a report on Tuesday, December 6th. Leerink Swann restated a “hold” rating on shares of Henry Schein in a report on Thursday, November 3rd. Finally, Gabelli upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $208.00 price target on the stock in a report on Tuesday, January 10th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and five have issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $181.35.
In other news, Director Kurt P. Kuehn bought 1,000 shares of Henry Schein stock in a transaction dated Monday, December 12th. The stock was bought at an average cost of $151.41 per share, for a total transaction of $151,410.00. Following the purchase, the director now directly owns 2,039 shares in the company, valued at approximately $308,724.99. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.27% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
This story was originally published by sleekmoney (http://sleekmoney.com) and is the sole property of sleekmoney. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at http://sleekmoney.com/gerstein-fisher-invests-295000-in-henry-schein-inc-hsic/1656992.html
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.